Patent · US Active

Polynucleotides encoding an actriib antibody

US9624301B2 · kind B2 · utility

3Cited by

6References

4Claims

0Family size

Assignees

Acceleron Pharma Inc. · US
Dyax Corp. · US

Inventors

Ravindra Kumar · Cambridge, US
Asya Grinberg · Lexington, US
Monique Davies · Chebeague Island, US
Diana Martik · Cambridge, US
Janja Cosic · Arlington, US
Rachel Kent · Boxborough, US
David Buckler · Mount Olive, US

Key dates

Filing date	Aug 11, 2016
Grant date	Apr 18, 2017
Priority date	—
Expiry date	Aug 11, 2036

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07K2319/30
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The disclosure provides, among other aspects, neutralizing antibodies and portions thereof that bind to ActRIIB and uses for same.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.